Matulac, Rogelio B.

HRN: 22-02-48  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
CEFTRIAXONE 1G (VIAL)
10/27/2022
11/03/2022
IV
2 Grams
Q24H
CAP-MR
Waiting Final Action 
10/27/2022
AZITHROMYCIN 500MG TABLET (TAB)
10/27/2022
11/01/2022
PO
1 Tab 500 Mg
OD
CAP-MR
Waiting Final Action 
10/30/2022
MUPIROCIN 2%, 15G (TUBE)
10/30/2022
11/05/2022
TOPICAL
1mg
BID
Bed Sores And Superficial Wound
Waiting Final Action 
11/01/2022
MUPIROCIN 2%, 15G (TUBE)
11/01/2022
11/07/2022
TOPICAL
2%
BID
Sacral Ulcer
Waiting Final Action 
11/01/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/01/2022
11/07/2022
IVT
1.5g
Q6
PTB, Sacral Ulcer
Waiting Final Action 
11/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/01/2022
11/07/2022
IVT
600mg
Q8
Sacral Ulcer
Waiting Final Action 
11/04/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/04/2022
11/10/2022
IV
3g
Q12
Sacral Ulcer, PTB (renal Dose Adjustment)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: